Wat Winnie Zee Man
Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Dent J (Basel). 2016 Oct 28;4(4):38. doi: 10.3390/dj4040038.
Medication-related osteonecrosis of the jaw (MRONJ) was first reported more than a decade ago. Since then, numerous cases have been diagnosed. Currently, there are three groups of drugs related to MRONJ: bisphosphonates, denosumab and anti-angiogenic drugs. As MRONJ can lead to debilitating clinical sequels and limited effective treatment options are available, much research has been done in understanding its pathophysiology. Until now, the exact pathogenesis of MRONJ has not been fully elucidated. While history of invasive dental procedures or local trauma may be present, some cases occur spontaneously without any preceding factors. This review aims to examine and discuss the three main hypotheses for the pathogenesis of MRONJ, namely suppressed bone turnover, cellular toxicity and infection.
药物相关性颌骨坏死(MRONJ)早在十多年前就有报道。从那时起,已诊断出大量病例。目前,有三类药物与MRONJ相关:双膦酸盐、地诺单抗和抗血管生成药物。由于MRONJ可导致使人衰弱的临床后果,且有效的治疗选择有限,因此在了解其病理生理学方面已开展了大量研究。到目前为止,MRONJ的确切发病机制尚未完全阐明。虽然可能存在侵入性牙科手术史或局部创伤史,但有些病例是在没有任何前期因素的情况下自发发生的。本综述旨在研究和讨论MRONJ发病机制的三个主要假说,即骨转换抑制、细胞毒性和感染。